glp-1 cardiovascular outcomes trial august 2025 Risks after Discontinuation GLP-1 Agonists in Cardiovascular Diseases:

By reducing fat mass, GLP-1 medications can naturally raise testosterone levels without exogenous replacement

After a few weeks, youll begin to see a trend that can tell you if you need to make a change

If you reach 6-8 weeks on an adequate dose with proper technique and see minimal results, the conversation with your provider should include discussing whether sublingual delivery is providing sufficient bioavailability for your needs, or whether transitioning to injectable administration might be more effective

Are pregnant, breastfeeding, or trying to conceive

Zhao L., Akmal, McGuckin MB, Li L, Wang Z, Larraeta E, Donnelly RF

In addition, in non-obese diabetic mice, DPP-IV inhibitors significantly increase Treg expansion and TGF- level